CytomX Therapeutics Inc (CTMX) stock news · rev $11.7M
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
This CTMX news page leads with what CytomX Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CTMX yet. We will not pad this page with generic market recap.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CTMX stock page; for the tape open the quote page.
Not investment advice.